Clinical Trials Using Oncolytic Type 2 Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor OH2
Review the clinical trials studying oncolytic type 2 herpes simplex virus expressing granulocyte macrophage colony-stimulating factor oh2 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.